Specifically, treatment with compound 44 significantly increased phosphorylation of 4E-BP1 and this effect was associated with a corresponding reduction in phosphorylated p70S6K and eIF-4E1 levels in these tumor cells. This evidence concerns the gene RPS6KB1 and neoplasm.